Carlos Murillo Almuzara, started his scientific carrier at The University of Zaragoza (Spain) where he studied biotechnology. His B.Sc. project, at BIOZAR research group, was based on the “Study of the cryopreservative effect of steroid hormones against cold-shock in ram spermatozoa”, gaining expertise in flow cytometry. He completed an Inter-university Master’s degree on Drug Discovery at the University of Alcalá, CEU San Pablo University, and Complutense University of Madrid, Spain. His M.Sc. Project, developed at CSIC, focused on the “Study of the methodological aspects of 19F NMR and its applications to molecular recognition studies”, setting up a novel strategy to study β-glycosidase inhibition and its reactivation by transglycosidation mechanism. Thereafter, he obtained a pre-doctoral fellowship to work at the Institute of Organic Chemistry and Biochemistry of Prague, Czech Republic where he analysed the capping process in vivo in E. coli by LC-MS. Currently, he is immersed in the ENDONANO Innovative Training Network: a European Industrial Doctorate project funded under the Marie Sklodowska-Cure Action of Horizon2020. In this context, he is working on the study of LPS detection assays exploiting the use of nanoparticles, fluorescence and optomagnetic properties. Such research takes place at ISA-CNR, Italy and at the company BluSense Diagnostics, Denmark. Simultaneously, he is enrolled in the PhD program of Medical Biology at PLUS University, Austria.